glp-1 agonist or antagonist Schematic illustration of monoagonists, dual agonists and triple glp-1 antagonist mechanism of action

Preferred subcutaneous sites include the abdomen and the outer upper arms, providing straightforward access for individuals administering their own injections: Abdomen: Injections are given at least two inches away from the navel, allowing for a broad area of fat tissue

Regular hormone panels, semen analyses, and symptom logs let clinicians adjust doses or swap agents to target true synergy rather than additive side effects

Targets tissue healing, gut integrity, joint recovery, and inflammation

Can infusion therapy help with recovery

Ipamorelin is produced through solid-phase peptide synthesis, a widely used method in laboratory settings